HNN3.0
Register
Register
Register

Project cooperationUpdated on 3 December 2025

Expertise in Human-Relevant NAMs and Advanced Safety Assessment

Head of Biomedicine and Cellular Toxicology at University of Burgos

Burgos, Spain

About

We offer strong expertise in advanced in vitro toxicology and NAMs-oriented method development, with validated 2D and 3D cellular models tailored to study sublethal, long-term exposures and mechanistic pathways relevant to human health. Our group has extensive experience implementing OECD-aligned testing strategies and developing reliable assays for chemical and material safety assessment. We complement these experimental capabilities with in silico tools for data analysis, AI-supported interpretation of transcriptomic responses, and integration of exposure and hazard information under FAIR principles. We actively contribute to European initiatives on Safe and Sustainable by Design (SSbD) and provides scientific recommendations, positioning us at the interface between research and regulatory translation. Through this combined experimental–computational expertise and regulatory engagement, we can significantly contribute to the development, optimisation and validation of scalable human-relevant NAMs platforms within this topic.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities

  • Project cooperation

    Translational Evidence Framework for Human-Relevant NAM Validation

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Emilien Nicolas

    R&D Preclinical manager at CER Groupe

    Aye, Belgium

  • Project cooperation

    Translational NAMs in pharmacology & toxicology for drug profiling

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Nikolas Dietis

    Assistant Professor of Pharmacology at University of Cyprus

    Nicosia, Cyprus

  • Project cooperation

    Salivary Liquid Biopsy as a Human-Relevant NAM for Regulatory and Biomedical Research

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Victoria Barygina

    progect manager at NSight Dynamics s.r.l.

    Florence, Italy